BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Covington
Chinese Patent Office
US Department of Justice
Farmers Insurance
Fuji
Citi
Merck
Cerilliant
Boehringer Ingelheim

Generated: January 24, 2018

DrugPatentWatch Database Preview

ESCITALOPRAM OXALATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for escitalopram oxalate and what is the scope of escitalopram oxalate freedom to operate?

Escitalopram oxalate
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Amneal Pharms, Antrim Pharms Llc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Silarx Pharms Inc, Taro, Forest Labs, Accord Hlthcare, Apotex Inc, Hikma Pharms, Invagen Pharms, Jubilant Generics, Lupin Ltd, Prinston Inc, Sti Pharma Llc, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Pharms Usa Inc, and is included in twenty-five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for escitalopram oxalate. Sixty-three suppliers are listed for this compound. There are six tentative approvals for this compound.
Summary for ESCITALOPRAM OXALATE
Pharmacology for ESCITALOPRAM OXALATE
Tentative approvals for ESCITALOPRAM OXALATE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe5MGTABLET; ORAL
➤ Subscribe➤ Subscribe20MGTABLET; ORAL
➤ Subscribe➤ Subscribe10MGTABLET; ORAL

US Patents and Regulatory Information for ESCITALOPRAM OXALATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078766-002 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 077550-001 May 14, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 090432-001 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Forest Labs LEXAPRO escitalopram oxalate SOLUTION;ORAL 021365-001 Nov 27, 2002 AA RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 205619-003 May 17, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078169-002 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 090432-003 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Forest Labs LEXAPRO escitalopram oxalate TABLET;ORAL 021323-003 Aug 14, 2002 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Torrent Pharms Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 090939-002 Sep 11, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sti Pharma Llc ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 077512-002 Sep 12, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ESCITALOPRAM OXALATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs LEXAPRO escitalopram oxalate SOLUTION;ORAL 021365-001 Nov 27, 2002 ➤ Subscribe ➤ Subscribe
Forest Labs LEXAPRO escitalopram oxalate TABLET;ORAL 021323-003 Aug 14, 2002 ➤ Subscribe ➤ Subscribe
Forest Labs LEXAPRO escitalopram oxalate TABLET;ORAL 021323-001 Aug 14, 2002 ➤ Subscribe ➤ Subscribe
Forest Labs LEXAPRO escitalopram oxalate TABLET;ORAL 021323-002 Aug 14, 2002 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Colorcon
Chinese Patent Office
Merck
Teva
Fish and Richardson
Dow
Novartis
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot